TXMD
TherapeuticsMD, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$2.21
−1.34%Leverage
- Debt / equity
- 0.20x
- Net debt / equity
- -0.13x
- Debt / assets
- 0.15x
- Debt / EBITDA
- -1.33x
- Net debt / EBITDA
- 0.86x
Liquidity & coverage
- Current ratio
- 3.22x
- Quick ratio
- 3.22x
- Cash ratio
- 1.84x
- Interest coverage
- -963.00x
- EBITDA / interest
- —
- Working capital
- $11.1M
Cash & dividend
- FCF / debt
- 0.56x
- Cash flow / debt
- 0.56x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026